DXS AND SANGTEC SIGN SCORPIONS TECHNOLOGY LICENSE PACT.DxS Ltd, a genotyping services and personalized medicine company, and Sangtec Molecular Diagnostics AB, a company specialized in developing and marketing standardized clinical molecular diagnostic tests, have signed a licence agreement for DxS' Scorpions[TM] technology. Under the terms of the agreement, Sangtec Molecular Diagnostics (SMD (1) (Storage Module Device) A high-performance hard disk interface used with minis and mainframes that transfers data in the 1-4 MBytes/sec range (SMD-E provides highest rate). See hard disk. ) will gain access to Scorpions for the development of human in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic kits in clinical diagnostics. Sweden-based SMD is a fully owned subsidiary of Germany-based Altana Pharma AG, the pharmaceutical group of Altana AG. Financial terms were not disclosed. Scorpions is a proprietary fluorescence-based nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. detection and genotyping system developed by DxS' founders. The technology provides an accurate, rapid and reliable signal generation system with applications in genotyping, infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. testing and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic expression profiling. Commenting on the agreement, Dr Eva Pisa, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of SMD, said: "DxS' Scorpions technology offers reliable and highly sensitive DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. detection, key attributes that will support the development of our PCR-based tests as we look to extend the range of products within our core markets of oncology and infectious disease. This is in line with our focus to develop and produce precise nucleic acid-based tests for the benefit of patients through improved diagnosis and tailoring of treatment regimes." Dr Steve Little, CEO of DxS, added: "We are delighted that SMD has chosen to use Scorpions for the expansion of its diagnostics portfolio. SMD has extensive experience in the development and production of PCR-based diagnostics. The company has a reputation for quality and safety, and a strong market position within Europe. We are excited that Scorpions is rapidly establishing itself as a valued technology among diagnostics providers. This is in addition to the confidence placed in Scorpions by our partners who access the technology via our clinical genotyping service." About DxS Ltd DxS is an established genotyping services company providing pharmaceutical, biotechnology and clinical research companies with rapid and reliable pharmacogenetic analysis to support drug discovery, clinical development and personalized medicine. DxS operates from purpose built laboratories equipped with fully automated sample handling and genotyping systems in Manchester, UK. The company has implemented industry-leading laboratory management systems and quality control practices. The DxS service is based on proprietary Scorpions[TM] technology that allows rapid and reliable PCR-based genotyping, and on SAFEspot[TM], a card-based sample collection system that greatly simplifies the storage and transport of blood spots blood spots spots of blood in hen eggs; an esthetic problem to the breakfast eater. They are of no disease significance and can be prevented by increasing the content of vitamin A in the diet. . Scorpions[TM] technology is also licensed to oligonucleotide suppliers and diagnostic companies, including Ortho-Clinical Diagnostics. For information about DxS, visit http://www.dxsgenotyping.com. About Sangtec Molecular Diagnostics AB Sangtec Molecular Diagnostics (SMD) is an innovative company specialized in developing, producing and marketing human clinical molecular diagnostic assays. The company was founded in 2001, but the research activities started in 1992, giving the company more than ten years of experience in its field. Today, SMD is one of the few companies with a worldwide PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) license for use in clinical diagnostics. SMD has a strong portfolio of Intellectual Property, including proprietary technologies, such as minisequencing, as well as in-licensed technologies, such as PCR and real-time PCR chemistry. The company has strong focus on total quality management, with ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. certification and CE label on all products, which are sold under the affigene trademark. SMD has more than ten years of experience in PCR-based diagnostics development and production. For more information, visit http://www.sangtec.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion